Investment Opportunity
Join the $4.45B Mobile Wound Care Revolution
Medipyxis is building the vertical SaaS operating system for mobile wound care — a large, high-growth specialty with no dominant software platform. We're early, we're moving fast, and the market timing is right.
$4.45B
Mobile wound care market
and growing
7-to-1
Tool consolidation
single platform replaces 7 separate tools
$72K
Revenue recovered
average in month 1 per client
>65M
Chronic wound patients
in the United States
The Investment Thesis
Six reasons Medipyxis is positioned to become the category-defining platform for mobile wound care.
A Large, Underserved Market
Mobile wound care is a $4.45 billion specialty with no dominant vertical software platform. The market runs on general EMRs, spreadsheets, and point-solution tools that were never designed for mobile, field-based care. The fragmentation creates opportunity for a purpose-built platform.
Vertical SaaS With High Retention
When a practice adopts Medipyxis, the platform becomes the operating system for the entire clinical and business workflow. Patient records, billing history, graft inventory, and compliance data all live inside. Switching costs are high. Net revenue retention is structurally strong.
Multiple Revenue Vectors
Medipyxis generates subscription revenue from clinical practices, transaction-based revenue from billing and revenue cycle services, and vendor portal access fees from graft and tissue vendors. As the platform scales, each vector compounds.
Regulatory Tailwinds
Medicare LCD requirements for wound care documentation are tightening. Audit rates are rising. Practices that are not using compliant, audit-ready documentation systems are increasingly at risk. Medipyxis is the compliance solution — not an optional upgrade.
Network Effects in the Supply Chain
When graft vendors connect their consignment inventory to Medipyxis, their product data flows directly into clinical workflows. As more vendors join, the platform becomes the de facto supply chain layer for mobile wound care — creating a two-sided network with defensible positions on both sides.
Early Traction, Right Timing
The mobile wound care market is consolidating. Independent practices are growing. Reimbursement reform is driving more wound care into the mobile setting. Medipyxis is positioned to become the category leader before larger incumbents prioritize this specialty.
Why Now
Healthcare reimbursement continues to shift care from expensive hospital and clinic settings into the community — SNFs, ALFs, and patient homes. Mobile wound care is a direct beneficiary of that shift. As the patient population grows and the regulatory environment tightens, practices that operate on outdated tool stacks will consolidate or fail.
Medipyxis is the platform those practices will run on. We're raising capital now to accelerate product development, expand the sales team, and establish category leadership before larger EMR incumbents prioritize this specialty.
Download the Pitch Deck
Fill out the form below to access the full investor deck. Your download will begin immediately after submission.
Investment Highlights
- $4.45B mobile wound care market with no dominant vertical platform
- 7-to-1 tool consolidation — high switching costs and strong retention
- Multiple revenue vectors: SaaS, RCM transactions, vendor portal fees
- Regulatory tailwinds: tightening LCD requirements drive urgency
- Network effects as graft vendors connect to the supply chain layer
- $72K average revenue recovered per client in month one
- Early-stage — positioned to establish category leadership now
Interested in Investing?
We're selective about our investor partners and value strategic alignment with our mission. If you're interested in learning more, reach out directly.